eflornithine has been researched along with Ototoxicity in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Ototoxicity: Damage to the EAR or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, CL | 1 |
| Havighurst, T | 1 |
| Lozar, T | 1 |
| Jones, TD | 1 |
| Kim, K | 1 |
| Bailey, HH | 1 |
1 trial available for eflornithine and Ototoxicity
| Article | Year |
|---|---|
Ototoxicity of Long-Term α-Difluoromethylornithine for Skin Cancer Prevention.
Topics: Eflornithine; Hearing; Hearing Loss; Humans; Ototoxicity; Skin Neoplasms | 2023 |